Amrutanjan Health Care Limited (AMRUTANJAN.NS)
INR 750.9
(-0.05%)
INR 750.9
(-0.05%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 420.3 Million | 192.18 Million | 521.95 Million | 897.62 Million | 181.76 Million | 211.68 Million |
| Net Income | 449.72 Million | 536.45 Million | 905.76 Million | 819.04 Million | 344.53 Million | 346.83 Million |
| Depreciation & Amortization | 60.56 Million | 52.11 Million | 37.95 Million | 36.69 Million | 43.59 Million | 32.55 Million |
| Deferred income taxes | - | -177.67 Million | -275.51 Million | -170.46 Million | - | - |
| Stock-based compensation | 2.15 Million | 4.37 Million | -113 Thousand | 6.17 Million | - | - |
| Change in working capital | -101.88 Million | -106.03 Million | -39.28 Million | 295.06 Million | -42.93 Million | -8.07 Million |
| Other non-cash items | 208.1 Million | -117.05 Million | -106.85 Million | -88.88 Million | -163.43 Million | -159.63 Million |
| Investing Cash Flow | 50.44 Million | -24.75 Million | -362.11 Million | -877.6 Million | -138.5 Million | -110.11 Million |
| Investments in PPE | -67.17 Million | -89.26 Million | -234.63 Million | -19.6 Million | -25.44 Million | -20.39 Million |
| Acquisitions | 2.58 Million | 48.24 Million | 253.82 Million | 894 Thousand | 61.47 Million | 700 Thousand |
| Investment purchases | - | -123.24 Million | -302.06 Million | -915.27 Million | -217.06 Million | -138.36 Million |
| Sales/Maturities of investments | 115.03 Million | 75 Million | 48.23 Million | -894 Thousand | 42.54 Million | -700 Thousand |
| Other Investing Activities | 258.82 Million | 64.51 Million | -127.48 Million | 57.27 Million | 1000.00 | 48.63 Million |
| Financing Cash Flow | -482.66 Million | -140.26 Million | -167.02 Million | -63.16 Million | -116.89 Million | -69.53 Million |
| Debt repayment | -5.57 Million | -5.8 Million | -70.67 Million | -12.52 Million | -5.63 Million | - |
| Dividends payments | -133.86 Million | -144.09 Million | -124.76 Million | -46.77 Million | -111 Million | -57 Million |
| Common Stock Repurchased | -355.01 Million | - | -35.33 Million | -9.64 Million | - | - |
| Common Stock Issuance | 11.78 Million | - | -35.33 Million | -9.64 Million | - | - |
| Other Financing Activities | -67.01 Million | -5.8 Million | 99.09 Million | 15.41 Million | -24.82 Million | -12.53 Million |
| Accounts receivables | -169.68 Million | 47.72 Million | -209.91 Million | 72.55 Million | 40.95 Million | -54.43 Million |
| Accounts payables | 95.4 Million | -106.66 Million | 236.78 Million | 94.99 Million | 16.18 Million | 34.33 Million |
| Inventory | -796 Thousand | -28.24 Million | -85.42 Million | 62.57 Million | -91.39 Million | -42.19 Million |
| Other working capital | -26.81 Million | -18.84 Million | 19.26 Million | 64.94 Million | -8.68 Million | 54.2 Million |
| Cash at beginning of period | 76.58 Million | 21.86 Million | 29.05 Million | 72.2 Million | 145.85 Million | 113.83 Million |
| Cash at end of period | 266.07 Million | 49.02 Million | 21.86 Million | 29.05 Million | 72.2 Million | 145.85 Million |
| Capital Expenditure | -67.17 Million | -89.26 Million | -234.63 Million | -19.6 Million | -25.44 Million | -20.39 Million |
| Effect of forex changes on cash | - | - | -2000.00 | -9000.00 | -10 Thousand | -7000.00 |
| Net cash flow / Change in cash | 189.49 Million | 27.16 Million | -7.18 Million | -43.15 Million | -73.64 Million | 32.02 Million |
| Free Cash Flow | 353.13 Million | 102.91 Million | 287.32 Million | 878.02 Million | 156.31 Million | 191.29 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 136.59 Million | 449.72 Million | 174.49 Million | 68.49 Million | 70.14 Million | 536.45 Million |
| Depreciation & Amortization | - | 60.56 Million | 15.76 Million | 15.54 Million | 13.92 Million | 52.11 Million |
| Deferred income taxes | - | - | - | - | - | -177.67 Million |
| Stock-based compensation | - | 2.15 Million | - | - | - | 4.37 Million |
| Change in working capital | - | -101.88 Million | - | - | - | -106.03 Million |
| Other non-cash items | -136.59 Million | 208.1 Million | -174.49 Million | -68.49 Million | -70.14 Million | -117.05 Million |
| Investing Cash Flow | - | 50.44 Million | - | - | - | -24.75 Million |
| Investments in PPE | - | -67.17 Million | - | - | - | -89.26 Million |
| Acquisitions | - | 2.58 Million | - | - | - | 48.24 Million |
| Investment purchases | - | - | - | - | - | -123.24 Million |
| Sales/Maturities of investments | - | 115.03 Million | - | - | - | 75 Million |
| Other Investing Activities | - | 258.82 Million | - | - | - | 64.51 Million |
| Financing Cash Flow | - | -482.66 Million | - | - | - | -140.26 Million |
| Debt repayment | - | -5.57 Million | - | - | - | -5.8 Million |
| Dividends payments | - | -133.86 Million | - | - | - | -144.09 Million |
| Common Stock Repurchased | - | -355.01 Million | - | - | - | - |
| Common Stock Issuance | - | 11.78 Million | - | - | - | - |
| Other Financing Activities | - | -67.01 Million | - | - | - | -5.8 Million |
| Accounts receivables | - | -169.68 Million | - | - | - | 47.72 Million |
| Accounts payables | - | 95.4 Million | - | - | - | -106.66 Million |
| Inventory | - | -796 Thousand | - | - | - | -28.24 Million |
| Other working capital | - | -26.81 Million | - | - | - | -18.84 Million |
| Cash at beginning of period | - | 76.58 Million | 500.86 Million | 469.77 Million | 76.58 Million | 21.86 Million |
| Cash at end of period | - | 266.07 Million | 532.39 Million | 500.86 Million | 104.42 Million | 49.02 Million |
| Capital Expenditure | - | -67.17 Million | - | - | - | -89.26 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 189.49 Million | 31.53 Million | 31.08 Million | 27.84 Million | 27.16 Million |
| Free Cash Flow | - | 353.13 Million | 31.53 Million | 31.08 Million | 27.84 Million | 102.91 Million |
4222
7443
VGAS
1619
1795
TRENT